|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cufari ME, Proli C, De Sousa P,
Raubenheimer H, Al Sahaf M, Chavan H, Shedden L, Niwaz Z, Leung M,
Nicholson AG, et al: Increasing frequency of non-smoking lung
cancer: Presentation of patients with early disease to a tertiary
institution in the UK. Eur J Cancer. 84:55–59. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sawabata N, Asamura H, Goya T, Mori M,
Nakanishi Y, Eguchi K, Koshiishi Y, Okumura M, Miyaoka E and Fujii
Y: Japanese Joint Committee for Lung Cancer Registry: Japanese Lung
Cancer Registry Study: First prospective enrollment of a large
number of surgical and nonsurgical cases in 2002. J Thorac Oncol.
5:1369–1375. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rosell R, Bivona TG and Karachaliou N:
Genetics and biomarkers in personalisation of lung cancer
treatment. Lancet. 382:720–731. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lindeman NI, Cagle PT, Aisner DL, Arcila
ME, Beasley MB, Bernicker EH, Colasacco C, Dacic S, Hirsch FR, Kerr
K, et al: Updated molecular testing guideline for the selection of
lung cancer patients for treatment with targeted tyrosine kinase
inhibitors: Guideline from the college of American pathologists,
the international association for the study of lung cancer, and the
association for molecular pathology. J Thorac Oncol. 13:323–358.
2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Dandachi N, Tiran V, Lindenmann J, Brcic
L, Fink-Neuboeck N, Kashofer K, Absenger G, Bezan A, Cote RJ, Datar
R and Balic M: Frequency and clinical impact of preoperative
circulating tumor cells in resectable non-metastatic lung
adenocarcinomas. Lung Cancer. 113:152–157. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hofman V, Ilie MI, Long E, Selva E,
Bonnetaud C, Molina T, Vénissac N, Mouroux J, Vielh P and Hofman P:
Detection of circulating tumor cells as a prognostic factor in
patients undergoing radical surgery for non-small-cell lung
carcinoma: Comparison of the efficacy of the CellSearch Assay™ and
the isolation by size of epithelial tumor cell method. Int J
Cancer. 129:1651–1660. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hosokawa M, Kenmotsu H, Koh Y, Yoshino T,
Yoshikawa T, Naito T, Takahashi T, Murakami H, Nakamura Y, Tsuya A,
et al: Size-based isolation of circulating tumor cells in lung
cancer patients using a microcavity array system. PLoS One.
8(e67466)2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Negishi R, Hosokawa M, Nakamura S, Kanbara
H, Kanetomo M, Kikuhara Y, Tanaka T, Matsunaga T and Yoshino T:
Development of the automated circulating tumor cell recovery system
with microcavity array. Biosens Bioelectron. 67:438–442.
2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hosokawa M, Yoshikawa T, Negishi R,
Yoshino T, Koh Y, Kenmotsu H, Naito T, Takahashi T, Yamamoto N,
Kikuhara Y, et al: Microcavity array system for size-based
enrichment of circulating tumor cells from the blood of patients
with small-cell lung cancer. Anal Chem. 85:5692–5698.
2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Qian C, Wu S, Chen H, Zhang X, Jing R,
Shen L, Wang X, Ju S, Jia C and Cong H: Clinical significance of
circulating tumor cells from lung cancer patients using
microfluidic chip. Clin Exp Med. 18:191–202. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bayarri-Lara C, Ortega FG, Cueto Ladrón de
Guevara A, Puche JL, Ruiz Zafra J, de Miguel-Pérez D, Ramos AS,
Giraldo-Ospina CF, Navajas Gómez JA, Delgado-Rodriguez M, et al:
Circulating tumor cells identify early recurrence in patients with
non-small cell lung cancer undergoing radical resection. PLoS One.
11(e0148659)2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Okumura Y, Tanaka F, Yoneda K, Hashimoto
M, Takuwa T, Kondo N and Hasegawa S: Circulating tumor cells in
pulmonary venous blood of primary lung cancer patients. Ann Thorac
Surg. 87:1669–1675. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Nawa T, Nakagawa T, Mizoue T, Kusano S,
Chonan T, Hayashihara K, Suito T and Endo K: A decrease in lung
cancer mortality following the introduction of low-dose chest CT
screening in Hitachi, Japan. Lung Cancer. 78:225–228.
2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Maheswaran S, Sequist LV, Nagrath S, Ulkus
L, Brannigan B, Collura CV, Inserra E, Diederichs S, Iafrate AJ,
Bell DW, et al: Detection of mutations in EGFR in circulating
lung-cancer cells. N Engl J Med. 359:366–377. 2008.PubMed/NCBI View Article : Google Scholar
|
